Soy, isoflavones, and prostate cancer

Molecular Nutrition and Food Research

Volumn 53, Issue 2, 2009, Pages 217-226

  Jlan, Le ^a  

^a CURTIN UNIVERSITY   (Australia)

Author keywords

Daidzein; Equol; Genistein; Isoflavones; Prostate cancer

Indexed keywords

ANTINEOPLASTIC AGENT; GENISTEIN; ISOFLAVONE DERIVATIVE;

BLOOD; HUMAN; LEGUME; MALE; PROSTATE TUMOR; REVIEW; SOYBEAN; VEGETABLE;

ANTICARCINOGENIC AGENTS; FABACEAE; GENISTEIN; HUMANS; ISOFLAVONES; MALE; PROSTATIC NEOPLASMS; SOYBEANS; VEGETABLES;

GLYCINE MAX;

EID: 60849134580     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800167     Document Type: Review

References (60)

1. World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective, AICR, Washington DC 2007.
2. Ferlay, J., Bray, F., Pisani, P., Parkin, D. M., GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC CancerBase No. 5, IARCPress, Lyon 2002.
3. Watanabe, M., Nakayama, T., Shiraishi, T., Stemmermann, G. N., Yatani, R., Comparative studies of prostate cancer in Japan versus the United States. A review, Urol. Oncol. 2000, 5,274-283.
4. Carter, B. S., Carter, H. B., Isaacs, J. T., Epidemiologic evidence regarding predisposing factors to prostate cancer, Prostate 1990, 16, 187-197.
5. Tominaga, S., Kuroishi, T., An ecological study on diet/nutrition and cancer in Japan, Int. J. Cancer 1991, 10, 2-6.
6. WHO, Mortality data base, WHO 2003.
7. Stewart, B. W., Kleihues, P., Would Cancer Report, IARC Press, Lyon 2003.
8. Adlercreutz, H., Phytoestrogens: Epidemiology and a possible role in cancer protection, Environ. Health Perspect. 1995, 103, 103-112.
9. Yildiz, F., Phytoestrogens in Functional Foods, CRC, Boca Raton, FL, 2005.
10. Linscheer, W., Vergroesen, A., in: Shils, M., Olson, J., Shike, M. (Eds.), Modern Nutrition in Health and Disease, Lea & Febiger, Philadelphia 1994, pp. 47-88.
11. Ganry, O., Phytoestrogens and prostate cancer risk, Prev. Med. 2005, 41, 1-6.
12. Anderson, J. W., Smith, B. M., Washnock, C. S., Cardiovascular and renal benefits of dry bean and soybean intake, Am. J. Clin. Nutr. 1999, 70, 464S-474S.
13. Wang, H. J., Murphy, R A., Isoflavone content in commercial soybean foods, J Agric. Food Chem. 1994, 42, 1666-1613.
14. Lampe, J. W., Isoflavonoid and lignan phytoestrogens as dietary biomarkers, J Nutr. 2003, 133, 956S-964S.
15. Vacek, J., Klejdus, B., Lojkova, L., Kuban, V., Current trends in isolation, separation, determination and identification of isoflavones: A review, J Sep. Sci. 2008, 31, 2054-2067.
16. Kudou, S., Tsuizaki, I., Uchida, T., Okubo, K., Purification and some properties of soybean saponin hydrolase from Aspergillus oryzae KO-2, Agric. Biol. Chem. 1991, 55, 31-36.
17. Wang, X. L., Hur, H. G., Lee, J. H., Kim, K. T., Kim, S. I., Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium, Appl. Environ. Microbiol. 2005, 71, 214-219.
18. Jacobsen, B. K., Knutsen, S. F., Fraser, G. E., Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (USA), Cancer Causes Control 1998, 9, 553-557.
19. Kurahashi, N., Iwasaki, M., Sasazuki, S., Otani, T., et al., Soy product and isoflavone consumption in relation to prostate cancer in Japanese men, Cancer Epidemiol. Biomarkers Prev. 2007, 16, 538-545.
20. Vastag, B., Soy and prostate cancer study results mixed, J Natl. Cancer Inst. 2007, 99, 1364-1365.
21. Lee, M. M., Gomez, S. L., Chang, J. S., Wey, M., et al., Soy and isoflavone consumption in relation to prostate cancer risk in China, Cancer Epidemiol. Biomarkers Prev. 2003, 12, 665-668.
22. Kolonel, L. N., Hankin, J. H., Whittemore, A. S., Wu, A. H., et al., Vegetables, fruits, legumes and prostate cancer: A multiethnic case-control study, Cancer Epidemiol. Biomarkers Prev. 2000, 9, 795 -804.
23. Strom, S. S., Yamamura, Y., Duphorne, C. M., Spitz, M. R., et al., Phytoestrogen intake and prostate cancer: A case-control study using a new database, Nutr. Cancer 1999, 33, 20-25.
24. Jain, M. G., Hislop, G. T., Howe, G. R., Ghadirian, P., Plant foods, antioxidants, and prostate cancer risk: Findings from case-control studies in Canada, Nutr. Cancer 1999, 34, 173-184.
25. Key, T. J., Silcocks, P. B., Davey, G. K., Appleby, R N., Bishop, D. T., A case-control study of diet and prostate cancerar. J Cancer 1991, 76, 678-687.
26. Heald, C. L., Ritchie, M. R., Bolton-Smith, C., Morton, M. S., Alexander, F. E., Phyto-oestrogens and risk of prostate cancer in Scottish men, Br. J Nutr. 2007, 95, 388-396.
27. Nomura, A. M., Hankin, J. H., Lee, J., Stemmermann, G. N., Cohort study of tofu intake and prostate cancer: No apparent association, Cancer Epidemiol. Biomarkers Prev. 2004, 13, 2277-2279.
28. Sonoda, T., Nagata, Y., Mori, M., Miyanaga, N., et al., A case-control study of diet and prostate cancer in Japan: Possible protective effect of traditional Japanese diet, Cancer Sci. 2004, 95, 238-242.
29. Villeneuve, P. J., Johnson, K. C., Kreiger, N., Mao, Y., Risk factors for prostate cancer: Results from the Canadian National Enhanced Cancer Surveillance System. The Canadian Cancer Registries Epidemiology Research Group, Cancer Causes Control 1999, 10, 355-367.
30. Sung, J. F., Lin, R. S., Pu, Y. S., Chen, Y. C., et al., Risk factors for prostate carcinoma in Taiwan: A case-control study in a Chinese population, Cancer 1999, 86, 484-491.
31. Severson, R. K., Nomura, A. M., Grove, J. S., Stemmermann, G. N., A prospective study of demographics, diet, and prostate cancer among men of Japanese ancestry in Hawaii, Cancer Res. 1989, 49, 1857-1860.
32. Allen, N. E., Sauvaget, C., Roddam, A. W., Appleby, P., et al., A prospective study of diet and prostate cancer in Japanese men, Cancer Causes Control 2004, 15, 911 -920.
33. Jian, L., Zhang, D. H., Lee, A. H., Binns, C. W., Do preserved foods increase prostate cancer risk? Br. J Cancer 2004, 90, 1192-1195.
34. Morton, M. S., Chan, R S., Cheng, C., Blacklock, N., et al., Lignans and isoflavonoids in plasma and prostatic fluid in men: Samples from Portugal, Hong Kong, and the United Kingdom, Prostate 1991, 32, 122-128.
35. Adlercreutz, H., Honjo, H., Higashi, A., Fotsis, T., et al., Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet, Am. J. Clin. Nutr. 1991, 54, 1093-1100.
36. Yuan, J. P., Wang, J. H., Liu, X., Metabolism of dietary soy isoflavones to equol by human intestinal microflora - implications for health, Mol. Nutr. Food Res. 2007, 51, 765-781.
37. Morton, M. S., Arisaka, O., Miyake, N., Morgan, L. D., Evans, B. A., Phytoestrogen concentrations in serum from Japanese men and women over forty years of age, J Nutr. 2002, 132, 3168-3171.
38. Akaza, H., Miyanaga, N., Takashima, N., Naito, S., et al., Is daidzein non-metabolizer a high risk for prostate cancer? A case-controlled study of serum soybean isoflavone concentration, Jpn. J Clin. Oncol. 2002, 32, 296-300.
39. Akaza, H., Miyanaga, N., Takashima, N., Naito, S., et al., Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents, Jpn. J. Clin. Oncol. 2004, 34, 86-89.
40. Ozasa, K., Nakao, M., Watanabe, Y., Hayashi, K., et al., Serum phytoestrogens and prostate cancer risk in a nested case-control study among Japanese men, Cancer Sci. 2004, 95, 65-71.
41. Li, Y., Sarkar, F. H., Gene expression profiles of genistein-treated PC3 prostate cancer cells, J Nutr. 2002, 132, 3623-3631.
42. Li, Y., Sarkar, F. H., Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein, Cancer Lett. 2002, 186, 157-164.
43. Davis, J. N., Kucuk, O., Sarkar, F H., Genistein inhibits NF-kappa B activation in prostate cancer cells, Nutr. Cancer 1999, 35, 161-114.
44. Raffoul, J. J., Wang, Y., Kucuk, O., Forman, J. D., et al., Genistein inhibits radiation-induced activation of NF-kappaB in prostate cancer cells promoting apoptosis and G2/M cell cycle arrest, BMC Cancer 2006, 6, 107.
45. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., et al., Genistein, a specific inhibitor of tyrosine-specific protein kinases, J. Biol. Chem. 1987, 262, 5592-5595.
46. Barnes, S., Peterson, T. G., Coward, L., Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer, J Cell Biochem. Suppl. 1995, 22, 181-187.
47. Djuric, Z., Chen, G., Doerge, D. R., Heilbrun, L. K., Kucuk, O., Effect of soy isoflavone supplementation on markers of oxidative stress in men and women, Cancer Lett. 2001, 172, 1-6.
48. Craft, C. S., Xu, L., Romero, D., Vary, C. P., Bergan, R. C., Genistein induces phenotypic reversion of endoglin deficiency in human prostate cancer cells, Mol. Pharmacol. 2008, 73, 235-242.
49. Xu, L., Bergan, R. C., Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway, Mol. Pharmacol. 2006, 70, 869-877.
50. Lakshman, M., Xu, L., Ananthanarayanan, V., Cooper, J. et al., Dietary genistein inhibits metastasis of human prostate cancer in mice, Cancer Res. 2008, 68, 2024-2032.
51. Pollard, M., Wolter, W., Prevention of spontaneous prostaterelated cancer in Lobund-Wistar rats by a soy protein isolate/isoflavone diet, Prostate 2000, 45, 101-105.
52. Wang, J., Eltoum, I. E., Lamartiniere, C. A., Dietary genistein suppresses chemically induced prostate cancer in LobundWistar rats, Cancer Lett. 2002, 186, 11-18.
53. Wang, J., Eltoum, I. E., Lamartiniere, C. A., Genistein chemoprevention of prostate cancer in TRAMP mice, J. Carcinog 2001, 6, 3.
54. Hamilton-Reeves, J. M., Rebello, S. A., Thomas, W., Slaton, J. W., Kurzer, M. S., Isoflavone-rich soy protein isolate suppresses androgen receptor expression without altering estrogen receptor-beta expression or serum hormonal profiles in men at high risk of prostate cancer, J. Nutr. 2007, 137, 1769-1775.
55. Bhatia, N., Agarwal, R., Detrimental effect of cancer preventive phytochemicals Silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells, Prostate 2001, 46, 98-107.
56. Yu, L., Blackburn, G. L., Zhou, J. R., Genistein and daidzein downregulate prostate androgen-regulated transcript-1 (PART-1) gene expression induced by dihydrotestosterone in human prostate LNCaP cancer cells, J Nutr. 2003, 133, 389-392.
57. Suzuki, K., Koike, H., Matsui, H., Ono, Y., et al., Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3, Int. J. Cancer 2002, 99, 846-852.
58. Castle, E. P., Thrasher, J. B., The role of soy phytoestrogens in prostate cancer, Urol. Clin. North Am. 2002, 29, 71-81, viii-ix.
59. Adlercreutz, H., Phyto-oestrogens and cancer, Lancet Oncol. 2002, 5, 364-373.
60. Nagata, Y., Sonoda, T., Mori, M., Miyanaga, N., et al., Dietary isoflavones may protect against prostate cancer in Japanese men, J Nutr. 2007, 137, 1974-1979.